Bagratee 2004

Methods	Computer‐generated random allocation of study number. Numbered envelopes containing misoprostol or placebo.
Participants	104 women who attended Early Pregnancy Unit, St Mary's Hospital, with incomplete miscarriage or early pregnancy failure < 13 weeks.
Interventions	600 mcg misoprostol (n = 52) or placebo [expectant management] (n = 52). Second dose next day unless complete miscarriage had occurred in meantime. Review day 7 and surgical evacuation if miscarriage not complete. Further review at day 14.
Outcomes	Primary: complete miscarriage without need for ERPC by day 7. Secondary outcomes: clinical, side‐effects, satisfaction and future choices.
Notes	Primary outcome reported for both non‐viable pregnancies and incomplete miscarriages, but not for secondary outcomes. These will be added if authors can provide data separately for non‐viable pregnancies and incomplete miscarriages.
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment (selection bias)	Low risk	A ‐ Adequate